Li Binghang,Li Mengting,He Lingnan,et al.. Inhibitory effect of AcSDKP on the proinflammatory profiles induced by lipopolysaccharides in a mouse RAW264.8 macrophage cell line in vitro[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 142-147.
[1] Wells RG Liver fibrosis:challenges of the new era. Gastroenterology,2009,136(2):387-388. [2] Wynn TA,Barron L Macrophages:master regulators of inflammation and fibrosis. Semin Liver Dis,2010,30(3):245-257. [3] Liu C,Tao Q,Sun M,et al. Kupffer cells are associated with apoptosis,inflammation and fibrotic effects in hepatic fibrosis in rats. Lab Invest,2010,90(12):1805-1816. [4] Pradelles P,Frobert Y,Creminon C,et al. Distribution of a negative regulator of haematopoietic stem cell proliferation (AcSDKP) and thymosin beta 4 in mouse tissues. FEBS Lett,1991,289(2):171-175. [5] Hu P,Li B, Zhang W,et al. AcSDKP regulates cell proliferation through the PI3KCA/Akt signaling pathway. PLoS One,2013,8(11):e79321. [6] Suzuki Y,Katagiri F,Sato F,et al. Significant decrease in plasma N-acetyl-seryl-aspartyl-lysyl-proline level in patients with end stage renal disease after kidney transplantation. Biol Pharm Bull,2014,37(6):1075-1079. [7] Nagai T,Kanasaki M, Srivastava SP,et al. N-acetyl-seryl-aspar tyl-lysyl-proline inhibits diabetes-associated kidney fibrosis and endothelial-mesenchymal transition. Biomed Res Int,2014,2014:696475. [8] Chen YW,Liu BW,Zhang YJ,et al. Preservation of basal AcSDKP attenuates carbon tetrachloride-induced fibrosis in the rat liver. J Hepatol,2010,53(3):528-536. [9] Hrenak J,Paulis L,Simko F. N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP):Potential target molecule in research of heart, kidney and brain. Curr Pharm Des,2015,21(35):5135-5143. [10] 陈源文,董国芳,徐雷鸣,等. 内源性AcSDKP及其前体胸腺素β4在四氯化碳致肝纤维化发生早期的变化. 胃肠病学和肝病学杂志,2010,19(1):6-9. [11] Haase-Kohn C,Wolf S,Herwig N,et al. Metastatic potential of B16-F10 melanoma cells is enhanced by extracellular S100A4 derived from RAW264.7 macrophages. Biochem Biophys Res Commun 2014,446(1):143-148. [12] Zimmermann HW,Tacke F. Modification of chemokine pathways and immune cell infiltration as a novel therapeutic approach in liver inflammation and fibrosis. Inflamm Allergy Drug Targets,2011,10(6):509-536. [13] 邵小娟,张艳梅,魏艳玲,等. NASH患者脂肪组织巨噬细胞计数的变化. 实用肝脏病杂志,2013,16(6):502-504. [14] Peng H,Carretero OA,Raij L,et al. Antifibrotic effects of N-acetyl-seryl-aspartyl-Lysyl-proline on the heart and kidney in aldosterone-salt hypertensive rats. Hypertension,2001,37(2 Pt 2):794-800. [15] Peng H,Carretero OA,Vuljaj N,et al. Angiotensin-converting enzyme inhibitors:a new mechanism of action. Circulation, 2005,112(16):2436-2445. [16] Rhaleb NE,Peng H,Yang XP,et al. Long-term effect of N-acetyl-seryl-aspartyl-lysyl-proline on left ventricular collagen deposition in rats with 2-kidney,1-clip hypertension. Circulation,2001,103(25):3136-3141. [17] Rhaleb NE,Peng H,Harding P,et al. Effect of N-acetyl-seryl- aspartyl-lysyl-proline on DNA and collagen synthesis in rat cardiac fibroblasts. Hypertension,2001,37(3):827-832. [18] Lin CX,Rhaleb NE,Yang XP,et al. Prevention of aortic fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol, 2008,295(3):H1253-h1261. [19] Zhu L,Yang XP,Janic B,et al. Ac-SDKP suppresses TNF-alpha-induced ICAM-1 expression in endothelial cells via inhibition of IkappaB kinase and NF-kappaB activation. Am J Physiol Heart Circ Physiol,2016,310(9):H1176-183. [20] Wang X,Sun Y,Zhao Y,et al. Oroxyloside prevents dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-kappaB pathway through PPARgamma activation. Biochem Pharmacol,2016,106:70-81. [21] Ma P,Ding YS,Xuan LL,et al. Anti-inflammatory effect of a resveratrol derivative 3,4,5-trimethoxy-4',5'-dihydroxy-trans-stilbene(WL-09-5) via ROS-mediated NF-kappaB pathway. J Asian Nat Prod Res,2016,20:1-10. [22] Wang J,Zhu R, Sun D,et al. Intracellular uptake of curcumin-loaded solid lipid nanoparticles exhibit anti-inflammatory activities superior to those of curcumin through the NF-kappa B signaling pathway. J Biomed Nanotechnol,2015,11(3):403-415. [23] Sun LD, Wang F,Dai F,et al. Development and mechanism investigation of a new piperlongumine derivative as a potent anti-inflammatory agent. Biochem Pharmacol,2015,95(3):156-169. [24] 何松美,刘霞,吴煜良,等. 草苁蓉乙醇提取物对NAFLD大鼠肝脏炎性因子表达的影响. 实用肝脏病杂志,2014,17(5):519-522. [25] Worou ME,Liao TD,D'Ambrosio M,et al. Renal protective effect of N-acetyl-seryl-aspartyl-lysyl-proline in dahl salt-sensi tive rats. Hypertension,2015,66(4):816-822.